CHLA Clinical Research Studies

Having volunteers participate in research studies and clinical trials is critical to our research efforts. Thousands of children and families are involved in our patient-centered studies every year. Many of the treatments used today are based on the results of past research studies and clinical trials conducted with our patients. Our scientific and clinical experts take the best ideas from the laboratory -- to the patient -- in the form of promising new treatments.

By searching our study directory, you may identify research that could impact the life of your child or of another child you know. Because the number of available research studies and clinical trials for children nationwide is small, every participant makes a significant contribution.

In addition to enrolling children with certain diseases in order to study treatments and prevention of those diseases, we also need to study healthy children. Ask your child’s doctor about volunteer study options that may be suitable for your child.

Please contact the study staff listed in your search results for more information.

Search by Keyword:    

Back to the full listing

Study Details - ID: CHLA-18-00086
Health/Science/Disease Category:
Eczema (AD)
Short Name:
Dupilumab (Dupixent) for skin infection in eczema
Full Title of Study:
Effect of Dupilumab (anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis - ATOPIC DERMATITIS RESEARCH NETWORK PROTOCOL-ADRN 09
Phase/Type of Study:
Phase 4
Purpose of Research:
To find out the effects of dupilumab (Dupixent) on skin infection in eczema
Eligibility:
Adults 18 to 65 years with moderate to severe eczema (atopic dermatitis)
Time Commitment/Requirements:
16 weeks with 11 visits. Compensation provided.
Primary Investigator:
Peck Ong, MD
Coordinator Contact Name:
Sydney Brown or Janet Jaime
Phone Number:
323-361-2501 or 323-361-4537
Email:
sybrown@chla.usc.edu or pyong@chla.usc.edu
Clinical Trials .Gov Identifier:
NCT03389893